Prospective Observational Basket Study of Stereotactic Body Radiation Therapy for OligoMetastatic Patients From Rare Tumors (PROMPT)
Prospective Observational Basket Study of Stereotactic Body Radiation Therapy for OligoMetastatic Patients From Rare Tumors: the PROMPT Study
Sponsor: Istituto Clinico Humanitas
Listed as NCT05903261, this observational or N/A phase trial focuses on Oligometastatic Disease and remains actively recruiting participants. Sponsored by Istituto Clinico Humanitas, it has been updated 4 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
4 versions recorded-
May 2025 — Present [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — May 2025 [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
-
Jul 2023 — Jul 2024 [monthly]
Not Yet Recruiting
First recorded
Jun 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Istituto Clinico Humanitas
For direct contact, visit the study record on ClinicalTrials.gov .